Search PubMed⌕ Search

Biomedical subjects

B Lerner

Publications and source records attributed to B Lerner.

16 recordsLinked to original sources

Automatic signal classification in fluorescence in situ hybridization images.

BACKGROUND: Previous systems for dot (signal) counting in fluorescence in situ hybridization (FISH) images have relied on an auto-focusing method for obtaining a clearly defined image. Because signals are distributed in three dimensions within the nucleus and artifacts such as debris and background fluorescence can attract the focusing method, valid signals can be left unfocused or unseen. This leads to dot counting errors, which increase with the number of probes. METHODS: The approach described here dispenses with auto-focusing, and instead relies on a neural network (NN) classifier that discriminates between in and out-of-focus images taken at different focal planes of the same field of view. Discrimination is performed by the NN, which classifies signals of each image as valid data or artifacts (due to out of focusing). The image that contains no artifacts is the in-focus image selected for dot count proportion estimation. RESULTS: Using an NN classifier and a set of features to represent signals improves upon previous discrimination schemes that are based on nonadaptable decision boundaries and single-feature signal representation. Moreover, the classifier is not limited by the number of probes. Three classification strategies, two of them hierarchical, have been examined and found to achieve each between 83% and 87% accuracy on unseen data. Screening, while performing dot counting, of in and out-of-focus images based on signal classification suggests an accurate and efficient alternative to that obtained using an auto-focusing mechanism.

Amniotic Fluid↗

GELFISH--graphical environment for labelling fluorescence in-situ hybridization images.

Signal (dot) counting in fluorescence in-situ hybridization (FISH) images that relies on an automatic focusing method for obtaining clearly defined images is a time-consuming procedure prone to errors. Our recently developed system has dispensed with automatic focusing, and instead relies on a neural network classifying focused and unfocused signals into valid and artefact data, respectively, and thereby discriminating between in- and out-of-focus images. However, to train the classifier accurate labelling of the image signals is required. GELFISH is a Graphical Environment for Labelling FISH images that enables the rejection of unanalysable nuclei and labelling of FISH signals simply and rapidly. GELFISH is flexible and can be modified easily for additional FISH applications. Also, implemented using popular software, the environment can be employed on any computer by any user. Finally, GELFISH is proposed in controlling a classifier-based dot counting system.

Artifacts↗

Human chromosome classification using multilayer perceptron neural network.

A multilayer perceptron (MLP) neural network (NN) has been studied for human chromosome classification. Only 10-20 examples were required for the MLP NN to reach its ultimate performance classifying chromosomes of 5 types. The empirical dependence of the entropic error on the number of examples was found to be highly comparable to the 1/t function. The principal component analysis (PCA) was used, both for network initialization and for feature reduction purposes. The PCA demonstrated the importance of retaining most of the image information whenever small training sets are used. The MLP NN classifier outperformed the Bayes piecewise classifier for all the cases tested. The MLP classifier was found to be almost unsusceptible to the ratio of the number of training vectors to the number of features, whereas the piecewise classifier was highly dependent on this ratio.

Algorithms↗

Diabetic retinopathy: recommendations for primary care management.

Diabetic retinopathy is a major cause of vision loss in the elderly, yet it is questionable whether sufficient cases are being diagnosed promptly enough for optimal therapy. The authors summarize the salient features in the development and progression of diabetic retinopathy, review the effectiveness of therapy, and discuss physician performance in conveying this therapy to diabetic patients. The authors emphasize the role of primary care in the referral of these patients.

Aged↗

[ECT in our time].

Explore the source record for details and available documents.

Electroconvulsive Therapy↗

Collateral circulation in patients with unstable angina.

Coronary collaterals were evaluated in 218 consecutive catheterized patients with unstable angina (defined as ischemic cardiac pain at rest associated with transient electrocardiographic changes). Collaterals were present in 106 patients (49 percent). The presence of collaterals correlated with the extent and severity of the coronary artery disease but not with age, sex, or risk factors. Among patients with comparable severity of narrowings, the presence of collaterals did not appear to protect against abnormal wall motion or pathologic Q waves on the ECG. In patients with single vessel disease, collaterals also did not appear to protect against transient ST segment evaluation during ischemia.

Age Factors↗

Inactivation of bacterial D-amino acid transaminase by beta-chloro-D-alanine.

Purified D-amino acid transaminase from Bacillus sphaericus catalyzes an alpha,beta elimination from the D isomer of beta-chloroalanine to yield equivalent amounts of pyruvate, chloride, and ammonia; the L isomer of chloroalanine is not a substrate for this transaminase. During the beta elimination there is a synchronous loss in enzyme activity; the Kinact for beta-chloroalanine was estimated to be about 10 micrometers. The alpha-aminoacrylate-Schiff base intermediate formed after beta elimination of chloride ion is probably the key intermediate that partitions between one inactivation event for every 1500 turnovers. In the presence of D-alanine and alpha-ketoglutarate, which are good substrates for the transaminase activity of this enzyme, beta-chloroalanine is a potent, competitive inhibitor (K1 = 10 micrometers) with D-alanine and a weak, uncompetitive inhibitor with alpha-ketoglutarate.

Alanine↗